Khan, E.A.; Cheddani, L.; Saint-Jacques, C.; Vargas-Poussou, R.; Frochot, V.; Chieze, R.; Letavernier, E.; Avellino, V.; Lionnet, F.; Haymann, J.-P.
Primary Hyperparathyroidism in Homozygous Sickle Cell Patients: A Hemolysis-Mediated Hypocalciuric Hypercalcemia Phenotype? J. Clin. Med. 2021, 10, 5179.
https://doi.org/10.3390/jcm10215179
AMA Style
Khan EA, Cheddani L, Saint-Jacques C, Vargas-Poussou R, Frochot V, Chieze R, Letavernier E, Avellino V, Lionnet F, Haymann J-P.
Primary Hyperparathyroidism in Homozygous Sickle Cell Patients: A Hemolysis-Mediated Hypocalciuric Hypercalcemia Phenotype? Journal of Clinical Medicine. 2021; 10(21):5179.
https://doi.org/10.3390/jcm10215179
Chicago/Turabian Style
Khan, Edmat Akhtar, Lynda Cheddani, Camille Saint-Jacques, Rosa Vargas-Poussou, Vincent Frochot, Remi Chieze, Emmanuel Letavernier, Virginie Avellino, Francois Lionnet, and Jean-Philippe Haymann.
2021. "Primary Hyperparathyroidism in Homozygous Sickle Cell Patients: A Hemolysis-Mediated Hypocalciuric Hypercalcemia Phenotype?" Journal of Clinical Medicine 10, no. 21: 5179.
https://doi.org/10.3390/jcm10215179
APA Style
Khan, E. A., Cheddani, L., Saint-Jacques, C., Vargas-Poussou, R., Frochot, V., Chieze, R., Letavernier, E., Avellino, V., Lionnet, F., & Haymann, J.-P.
(2021). Primary Hyperparathyroidism in Homozygous Sickle Cell Patients: A Hemolysis-Mediated Hypocalciuric Hypercalcemia Phenotype? Journal of Clinical Medicine, 10(21), 5179.
https://doi.org/10.3390/jcm10215179